ID   SYMC_HUMAN              Reviewed;         900 AA.
AC   P56192; B3KVK7; Q14895; Q53H14; Q96A15; Q96BZ0; Q9NSE0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Methionine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.10;
DE   AltName: Full=Methionyl-tRNA synthetase;
DE            Short=MetRS;
GN   Name=MARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Gastric carcinoma;
RX   PubMed=8921912; DOI=10.1016/0378-1119(96)00313-7;
RA   Lage H., Dietel M.;
RT   "Cloning of a human cDNA encoding a protein with high homology to
RT   yeast methionyl-tRNA synthetase.";
RL   Gene 178:187-189(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Motegi H., Noda T., Shiba K.;
RT   "Cloning and sequence determination of a human cytoplasmic methionyl-
RT   tRNA synthetase gene.";
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Colon, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   INVOLVEMENT IN CMT2U, VARIANT CMT2U CYS-618, AND CHARACTERIZATION OF
RP   VARIANT CMT2U CYS-618.
RX   PubMed=23729695; DOI=10.1136/jnnp-2013-305049;
RG   Inherited Neuropathy Consortium;
RA   Gonzalez M., McLaughlin H., Houlden H., Guo M., Yo-Tsen L.,
RA   Hadjivassilious M., Speziani F., Yang X.L., Antonellis A.,
RA   Reilly M.M., Zuchner S.;
RT   "Exome sequencing identifies a significant variant in methionyl-tRNA
RT   synthetase (MARS) in a family with late-onset CMT2.";
RL   J. Neurol. Neurosurg. Psych. 84:1247-1249(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN CMT2U, AND VARIANT CMT2U THR-800.
RX   PubMed=24354524; DOI=10.1111/cge.12327;
RA   Hyun Y.S., Park H.J., Heo S.H., Yoon B.R., Nam S.H., Kim S.B.,
RA   Park C.I., Choi B.O., Chung K.W.;
RT   "Rare variants in methionyl- and tyrosyl-tRNA synthetase genes in
RT   late-onset autosomal dominant Charcot-Marie-Tooth neuropathy.";
RL   Clin. Genet. 86:592-594(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 835-900.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the WHEP-TRS domain of human methionyl-tRNA
RT   synthetase.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [19]
RP   INVOLVEMENT IN ILLD, AND VARIANTS ILLD LEU-370 AND THR-523.
RX   PubMed=24103465; DOI=10.1186/1471-2350-14-106;
RA   van Meel E., Wegner D.J., Cliften P., Willing M.C., White F.V.,
RA   Kornfeld S., Cole F.S.;
RT   "Rare recessive loss-of-function methionyl-tRNA synthetase mutations
RT   presenting as a multi-organ phenotype.";
RL   BMC Med. Genet. 14:106-106(2013).
RN   [20]
RP   VARIANTS MET-5 AND TRP-702.
RX   PubMed=24482476; DOI=10.1126/science.1247363;
RA   Novarino G., Fenstermaker A.G., Zaki M.S., Hofree M., Silhavy J.L.,
RA   Heiberg A.D., Abdellateef M., Rosti B., Scott E., Mansour L.,
RA   Masri A., Kayserili H., Al-Aama J.Y., Abdel-Salam G.M., Karminejad A.,
RA   Kara M., Kara B., Bozorgmehri B., Ben-Omran T., Mojahedi F.,
RA   Mahmoud I.G., Bouslam N., Bouhouche A., Benomar A., Hanein S.,
RA   Raymond L., Forlani S., Mascaro M., Selim L., Shehata N.,
RA   Al-Allawi N., Bindu P.S., Azam M., Gunel M., Caglayan A., Bilguvar K.,
RA   Tolun A., Issa M.Y., Schroth J., Spencer E.G., Rosti R.O., Akizu N.,
RA   Vaux K.K., Johansen A., Koh A.A., Megahed H., Durr A., Brice A.,
RA   Stevanin G., Gabriel S.B., Ideker T., Gleeson J.G.;
RT   "Exome sequencing links corticospinal motor neuron disease to common
RT   neurodegenerative disorders.";
RL   Science 343:506-511(2014).
RN   [21]
RP   VARIANTS ILLD CYS-344; THR-393; LEU-567 AND VAL-605, AND VARIANTS
RP   LEU-206 AND GLN-727.
RX   PubMed=25913036; DOI=10.1016/j.ajhg.2015.03.010;
RA   Hadchouel A., Wieland T., Griese M., Baruffini E.,
RA   Lorenz-Depiereux B., Enaud L., Graf E., Dubus J.C.,
RA   Halioui-Louhaichi S., Coulomb A., Delacourt C., Eckstein G.,
RA   Zarbock R., Schwarzmayr T., Cartault F., Meitinger T., Lodi T.,
RA   de Blic J., Strom T.M.;
RT   "Biallelic mutations of methionyl-tRNA synthetase cause a specific
RT   type of pulmonary alveolar proteinosis prevalent on Reunion island.";
RL   Am. J. Hum. Genet. 96:826-831(2015).
CC   -!- CATALYTIC ACTIVITY: ATP + L-methionine + tRNA(Met) = AMP +
CC       diphosphate + L-methionyl-tRNA(Met).
CC   -!- SUBUNIT: Component of the multisynthetase complex which is
CC       comprised of a bifunctional glutamyl-prolyl-tRNA synthetase, the
CC       monospecific isoleucyl, leucyl, glutaminyl, methionyl, lysyl,
CC       arginyl, and aspartyl-tRNA synthetases as well as three auxiliary
CC       proteins, p18, p48 and p43.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P56192-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56192-2; Sequence=VSP_056563, VSP_056564;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Interstitial lung and liver disease (ILLD) [MIM:615486]:
CC       An autosomal recessive, life-threatening disorder characterized by
CC       respiratory insufficiency and progressive liver disease with onset
CC       in infancy or early childhood. Clinical features include failure
CC       to thrive, hypotonia, intermittent lactic acidosis, aminoaciduria,
CC       hypothyroidism, interstitial lung disease, pulmonary alveolar
CC       proteinosis, anemia, and liver canalicular cholestasis, steatosis,
CC       and iron deposition. {ECO:0000269|PubMed:24103465,
CC       ECO:0000269|PubMed:25913036}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2U (CMT2U) [MIM:616280]: An
CC       axonal form of Charcot-Marie-Tooth disease, a disorder of the
CC       peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the
CC       distal muscles of the arms. Charcot-Marie-Tooth disease is
CC       classified in two main groups on the basis of electrophysiologic
CC       properties and histopathology: primary peripheral demyelinating
CC       neuropathies (designated CMT1 when they are dominantly inherited)
CC       and primary peripheral axonal neuropathies (CMT2). Neuropathies of
CC       the CMT2 group are characterized by signs of axonal degeneration
CC       in the absence of obvious myelin alterations, normal or slightly
CC       reduced nerve conduction velocities, and progressive distal muscle
CC       weakness and atrophy. CMT2U is a slowly progressive, autosomal
CC       dominant form characterized by late-adult onset.
CC       {ECO:0000269|PubMed:23729695, ECO:0000269|PubMed:24354524}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X94754; CAA64381.1; -; mRNA.
DR   EMBL; Z49216; CAA89153.1; -; mRNA.
DR   EMBL; D84224; BAA95668.1; -; mRNA.
DR   EMBL; BT007338; AAP36002.1; -; mRNA.
DR   EMBL; AK122956; BAG53819.1; -; mRNA.
DR   EMBL; AK222767; BAD96487.1; -; mRNA.
DR   EMBL; AC022506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002384; AAH02384.1; -; mRNA.
DR   EMBL; BC006328; AAH06328.1; -; mRNA.
DR   EMBL; BC011639; AAH11639.1; -; mRNA.
DR   EMBL; BC011849; AAH11849.1; -; mRNA.
DR   EMBL; BC015011; AAH15011.1; -; mRNA.
DR   CCDS; CCDS8942.1; -. [P56192-1]
DR   PIR; JC5224; JC5224.
DR   RefSeq; NP_004981.2; NM_004990.3. [P56192-1]
DR   UniGene; Hs.632707; -.
DR   PDB; 2DJV; NMR; -; A=835-900.
DR   PDB; 4BL7; X-ray; 1.89 A; A=1-224.
DR   PDB; 4BVX; X-ray; 1.60 A; A=1-207.
DR   PDB; 4BVY; X-ray; 1.99 A; A=1-225.
DR   PDBsum; 2DJV; -.
DR   PDBsum; 4BL7; -.
DR   PDBsum; 4BVX; -.
DR   PDBsum; 4BVY; -.
DR   ProteinModelPortal; P56192; -.
DR   SMR; P56192; -.
DR   BioGrid; 110311; 69.
DR   DIP; DIP-38164N; -.
DR   IntAct; P56192; 26.
DR   MINT; MINT-5004366; -.
DR   STRING; 9606.ENSP00000262027; -.
DR   BindingDB; P56192; -.
DR   ChEMBL; CHEMBL2870; -.
DR   DrugBank; DB00134; L-Methionine.
DR   MoonProt; P56192; -.
DR   iPTMnet; P56192; -.
DR   PhosphoSitePlus; P56192; -.
DR   SwissPalm; P56192; -.
DR   BioMuta; MARS; -.
DR   DMDM; 20178332; -.
DR   EPD; P56192; -.
DR   MaxQB; P56192; -.
DR   PaxDb; P56192; -.
DR   PeptideAtlas; P56192; -.
DR   PRIDE; P56192; -.
DR   DNASU; 4141; -.
DR   Ensembl; ENST00000262027; ENSP00000262027; ENSG00000166986. [P56192-1]
DR   Ensembl; ENST00000537638; ENSP00000446168; ENSG00000166986. [P56192-2]
DR   GeneID; 4141; -.
DR   KEGG; hsa:4141; -.
DR   UCSC; uc001sof.2; human. [P56192-1]
DR   CTD; 4141; -.
DR   DisGeNET; 4141; -.
DR   GeneCards; MARS; -.
DR   GeneCards; MIR6758; -.
DR   HGNC; HGNC:6898; MARS.
DR   HPA; CAB017097; -.
DR   HPA; HPA004125; -.
DR   MalaCards; MARS; -.
DR   MIM; 156560; gene.
DR   MIM; 615486; phenotype.
DR   MIM; 616280; phenotype.
DR   neXtProt; NX_P56192; -.
DR   OpenTargets; ENSG00000166986; -.
DR   Orphanet; 370088; Acute infantile liver failure-multisystemic involvement syndrome.
DR   Orphanet; 397735; Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MARS mutation.
DR   Orphanet; 401835; Autosomal recessive spastic paraplegia type 70.
DR   PharmGKB; PA30642; -.
DR   eggNOG; KOG0867; Eukaryota.
DR   eggNOG; KOG1247; Eukaryota.
DR   eggNOG; COG0143; LUCA.
DR   GeneTree; ENSGT00550000075017; -.
DR   HOGENOM; HOG000200402; -.
DR   HOVERGEN; HBG036191; -.
DR   InParanoid; P56192; -.
DR   KO; K01874; -.
DR   OMA; HPGCGYE; -.
DR   OrthoDB; EOG091G020Y; -.
DR   PhylomeDB; P56192; -.
DR   TreeFam; TF300526; -.
DR   BRENDA; 6.1.1.10; 2681.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   SignaLink; P56192; -.
DR   SIGNOR; P56192; -.
DR   ChiTaRS; MARS; human.
DR   EvolutionaryTrace; P56192; -.
DR   GeneWiki; MARS_(gene); -.
DR   GenomeRNAi; 4141; -.
DR   PRO; PR:P56192; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000166986; -.
DR   CleanEx; HS_MARS; -.
DR   ExpressionAtlas; P56192; baseline and differential.
DR   Genevisible; P56192; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IDA:CAFA.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:CAFA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004825; F:methionine-tRNA ligase activity; TAS:Reactome.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:CAFA.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:CAFA.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IDA:CAFA.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:CAFA.
DR   GO; GO:0006431; P:methionyl-tRNA aminoacylation; IEA:InterPro.
DR   GO; GO:1901838; P:positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IMP:CAFA.
DR   GO; GO:0009303; P:rRNA transcription; IMP:CAFA.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; IBA:GO_Central.
DR   CDD; cd00814; MetRS_core; 1.
DR   Gene3D; 1.10.730.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00098; Met_tRNA_synth_type1; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR004046; GST_C.
DR   InterPro; IPR023458; Met-tRNA_ligase_1.
DR   InterPro; IPR014758; Met-tRNA_synth.
DR   InterPro; IPR015413; Methionyl/Leucyl_tRNA_Synth.
DR   InterPro; IPR033911; MetRS_core.
DR   InterPro; IPR029038; MetRS_Zn.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009068; S15_NS1_RNA-bd.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR000738; WHEP-TRS_dom.
DR   Pfam; PF00043; GST_C; 1.
DR   Pfam; PF09334; tRNA-synt_1g; 1.
DR   Pfam; PF00458; WHEP-TRS; 1.
DR   PRINTS; PR01041; TRNASYNTHMET.
DR   SMART; SM00991; WHEP-TRS; 1.
DR   SUPFAM; SSF47060; SSF47060; 1.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF57770; SSF57770; 1.
DR   TIGRFAMs; TIGR00398; metG; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS00762; WHEP_TRS_1; 1.
DR   PROSITE; PS51185; WHEP_TRS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aminoacyl-tRNA synthetase;
KW   ATP-binding; Charcot-Marie-Tooth disease; Complete proteome;
KW   Cytoplasm; Disease mutation; Ligase; Neurodegeneration; Neuropathy;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Protein biosynthesis; Reference proteome; RNA-binding; tRNA-binding.
FT   CHAIN         1    900       Methionine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000139262.
FT   DOMAIN       74    198       GST C-terminal.
FT   DOMAIN      841    897       WHEP-TRS.
FT   MOTIF       273    283       "HIGH" region.
FT   MOTIF       593    597       "KMSKS" region.
FT   BINDING     596    596       ATP. {ECO:0000250}.
FT   MOD_RES     825    825       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FL6}.
FT   MOD_RES     835    835       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q68FL6}.
FT   VAR_SEQ     546    546       V -> P (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056563.
FT   VAR_SEQ     547    900       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056564.
FT   VARIANT       5      5       V -> M (found in a patient with spastic
FT                                paraplegia; unknown pathological
FT                                significance; dbSNP:rs587777227).
FT                                {ECO:0000269|PubMed:24482476}.
FT                                /FTId=VAR_077848.
FT   VARIANT     206    206       P -> L (in dbSNP:rs138776588).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075360.
FT   VARIANT     344    344       Y -> C (in ILLD; when assayed in yeast,
FT                                induces a slight growth retardation and
FT                                reduction in methionine incorporation;
FT                                may interfere with efficient substrate
FT                                binding; dbSNP:rs766466297).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075361.
FT   VARIANT     370    370       F -> L (in ILLD; dbSNP:rs140467171).
FT                                {ECO:0000269|PubMed:24103465}.
FT                                /FTId=VAR_070872.
FT   VARIANT     393    393       A -> T (in ILLD; may act as a disease
FT                                modifier aggravating the phenotype; found
FT                                in patients that carried additional
FT                                mutations C-344 and/or L-567; when
FT                                assayed in yeast, does not exhibit any
FT                                phenotype; when assayed in yeast in
FT                                association with L-567, increases L-567-
FT                                induced growth retardation and reduction
FT                                in methionine incorporation;
FT                                dbSNP:rs141340466).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075362.
FT   VARIANT     523    523       I -> T (in ILLD; dbSNP:rs201555303).
FT                                {ECO:0000269|PubMed:24103465}.
FT                                /FTId=VAR_070873.
FT   VARIANT     567    567       S -> L (in ILLD; when assayed in yeast,
FT                                reduces methionine incorporation; when
FT                                assayed in yeast in association with T-
FT                                393, induces growth retardation and
FT                                strong reduction in methionine
FT                                incorporation; may interfere with
FT                                efficient substrate binding;
FT                                dbSNP:rs143592405).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075363.
FT   VARIANT     605    605       D -> V (in ILLD; when assayed in yeast,
FT                                induces a slight growth retardation and
FT                                reduction in methionine incorporation;
FT                                may interfere with efficient substrate
FT                                binding; dbSNP:rs756021768).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075364.
FT   VARIANT     618    618       R -> C (in CMT2U; loss of function
FT                                mutation; dbSNP:rs587777718).
FT                                {ECO:0000269|PubMed:23729695}.
FT                                /FTId=VAR_073377.
FT   VARIANT     683    683       A -> D (in dbSNP:rs1054403).
FT                                /FTId=VAR_020459.
FT   VARIANT     702    702       R -> W (found in a patient with spastic
FT                                paraplegia; unknown pathological
FT                                significance; dbSNP:rs587777228).
FT                                {ECO:0000269|PubMed:24482476}.
FT                                /FTId=VAR_077849.
FT   VARIANT     727    727       R -> Q (in dbSNP:rs113808165).
FT                                {ECO:0000269|PubMed:25913036}.
FT                                /FTId=VAR_075365.
FT   VARIANT     800    800       P -> T (in CMT2U; dbSNP:rs781249411).
FT                                {ECO:0000269|PubMed:24354524}.
FT                                /FTId=VAR_073378.
FT   CONFLICT     53     53       L -> V (in Ref. 1; CAA64381).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       A -> P (in Ref. 1; CAA64381).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       L -> Q (in Ref. 1; CAA64381).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       W -> S (in Ref. 7; AAH15011).
FT                                {ECO:0000305}.
FT   CONFLICT    250    250       L -> P (in Ref. 5; BAD96487).
FT                                {ECO:0000305}.
FT   CONFLICT    683    683       A -> G (in Ref. 1; CAA64381/CAA89153).
FT                                {ECO:0000305}.
FT   STRAND        2      5       {ECO:0000244|PDB:4BVX}.
FT   HELIX        12     18       {ECO:0000244|PDB:4BVX}.
FT   HELIX        19     22       {ECO:0000244|PDB:4BVX}.
FT   TURN         23     25       {ECO:0000244|PDB:4BVX}.
FT   STRAND       29     32       {ECO:0000244|PDB:4BVX}.
FT   STRAND       48     52       {ECO:0000244|PDB:4BVX}.
FT   HELIX        62     72       {ECO:0000244|PDB:4BVX}.
FT   HELIX        79     90       {ECO:0000244|PDB:4BVX}.
FT   HELIX        92    104       {ECO:0000244|PDB:4BVX}.
FT   HELIX       111    114       {ECO:0000244|PDB:4BVX}.
FT   HELIX       115    117       {ECO:0000244|PDB:4BVX}.
FT   HELIX       118    130       {ECO:0000244|PDB:4BVX}.
FT   STRAND      131    140       {ECO:0000244|PDB:4BVX}.
FT   HELIX       143    156       {ECO:0000244|PDB:4BVX}.
FT   HELIX       159    161       {ECO:0000244|PDB:4BVX}.
FT   HELIX       167    177       {ECO:0000244|PDB:4BVX}.
FT   HELIX       180    190       {ECO:0000244|PDB:4BVX}.
FT   HELIX       194    198       {ECO:0000244|PDB:4BVX}.
FT   HELIX       199    202       {ECO:0000244|PDB:4BVX}.
FT   HELIX       838    861       {ECO:0000244|PDB:2DJV}.
FT   HELIX       866    887       {ECO:0000244|PDB:2DJV}.
FT   STRAND      893    895       {ECO:0000244|PDB:2DJV}.
FT   STRAND      897    899       {ECO:0000244|PDB:2DJV}.
SQ   SEQUENCE   900 AA;  101116 MW;  3D687C77E17C5C96 CRC64;
     MRLFVSDGVP GCLPVLAAAG RARGRAEVLI STVGPEDCVV PFLTRPKVPV LQLDSGNYLF
     STSAICRYFF LLSGWEQDDL TNQWLEWEAT ELQPALSAAL YYLVVQGKKG EDVLGSVRRA
     LTHIDHSLSR QNCPFLAGET ESLADIVLWG ALYPLLQDPA YLPEELSALH SWFQTLSTQE
     PCQRAAETVL KQQGVLALRP YLQKQPQPSP AEGRAVTNEP EEEELATLSE EEIAMAVTAW
     EKGLESLPPL RPQQNPVLPV AGERNVLITS ALPYVNNVPH LGNIIGCVLS ADVFARYSRL
     RQWNTLYLCG TDEYGTATET KALEEGLTPQ EICDKYHIIH ADIYRWFNIS FDIFGRTTTP
     QQTKITQDIF QQLLKRGFVL QDTVEQLRCE HCARFLADRF VEGVCPFCGY EEARGDQCDK
     CGKLINAVEL KKPQCKVCRS CPVVQSSQHL FLDLPKLEKR LEEWLGRTLP GSDWTPNAQF
     ITRSWLRDGL KPRCITRDLK WGTPVPLEGF EDKVFYVWFD ATIGYLSITA NYTDQWERWW
     KNPEQVDLYQ FMAKDNVPFH SLVFPCSALG AEDNYTLVSH LIATEYLNYE DGKFSKSRGV
     GVFGDMAQDT GIPADIWRFY LLYIRPEGQD SAFSWTDLLL KNNSELLNNL GNFINRAGMF
     VSKFFGGYVP EMVLTPDDQR LLAHVTLELQ HYHQLLEKVR IRDALRSILT ISRHGNQYIQ
     VNEPWKRIKG SEADRQRAGT VTGLAVNIAA LLSVMLQPYM PTVSATIQAQ LQLPPPACSI
     LLTNFLCTLP AGHQIGTVSP LFQKLENDQI ESLRQRFGGG QAKTSPKPAV VETVTTAKPQ
     QIQALMDEVT KQGNIVRELK AQKADKNEVA AEVAKLLDLK KQLAVAEGKP PEAPKGKKKK
//
